Glycoprotein News and Research

RSS
Study of glycosylation on SARS-CoV-2 spike protein

Study of glycosylation on SARS-CoV-2 spike protein

Gene expression networks flag potential therapeutic targets for SARS-CoV-2

Gene expression networks flag potential therapeutic targets for SARS-CoV-2

Oxford COVID-19 vaccine trials move to stage 3 human trials

Oxford COVID-19 vaccine trials move to stage 3 human trials

Study: Variation in COVID-19 viral genome improves its ability to infect human cells

Study: Variation in COVID-19 viral genome improves its ability to infect human cells

Mutated European strain of coronavirus more contagious but less potent

Mutated European strain of coronavirus more contagious but less potent

Novavax SARS-CoV-2 vaccine candidate shows promise in animal models

Novavax SARS-CoV-2 vaccine candidate shows promise in animal models

Repurposed drug for acute lung injury in COVID-19

Repurposed drug for acute lung injury in COVID-19

Striking CryoEM image of SARS-CoV-2

Striking CryoEM image of SARS-CoV-2

A glycan analysis of SARS-CoV-2 ACE2 complex

A glycan analysis of SARS-CoV-2 ACE2 complex

COVID-19 patients can rapidly generate virus-attacking T cells, shows study

COVID-19 patients can rapidly generate virus-attacking T cells, shows study

Genes associated with SARS-CoV-2 human lung cell infection

Genes associated with SARS-CoV-2 human lung cell infection

Early childhood vaccinations may offer protection against COVID-19

Early childhood vaccinations may offer protection against COVID-19

Effective neutralization of SARS-CoV-2 by synthetic nanobodies targeting the spike protein

Effective neutralization of SARS-CoV-2 by synthetic nanobodies targeting the spike protein

Structured 'cut-and-paste' design enables streamlined development of SARS-CoV-2 molecular probes

Structured 'cut-and-paste' design enables streamlined development of SARS-CoV-2 molecular probes

Antibodies against prevalent endemic human coronaviruses may provide cross-protection to SARS-CoV-2

Antibodies against prevalent endemic human coronaviruses may provide cross-protection to SARS-CoV-2

Pangolin version of SARS-CoV-2 can cause COVID-19-like illness

Pangolin version of SARS-CoV-2 can cause COVID-19-like illness

First clinical trial in South Africa for Covid-19 vaccine begins

First clinical trial in South Africa for Covid-19 vaccine begins

Single-dose Israeli vaccine candidate protective against SARS-CoV-2

Single-dose Israeli vaccine candidate protective against SARS-CoV-2

A highly sensitive and specific antibody test for COVID-19

A highly sensitive and specific antibody test for COVID-19

Direct structural link between SARS-CoV-2 and essential fatty acid

Direct structural link between SARS-CoV-2 and essential fatty acid